Sector Gamma ASA
Latest statistics and disclosures from Sector Gamma As's latest quarterly 13F-HR filing:
- Top 5 stock holdings are BMY, MRK, PFE, MDT, INCY, and represent 36.69% of Sector Gamma As's stock portfolio.
- Added to shares of these 10 stocks: UNH (+$9.9M), ABT (+$9.0M), IQV (+$6.9M), PFE (+$6.5M), QGEN (+$6.5M), BMY, ELV, HUM, BBIO, IOVA.
- Started 11 new stock positions in BBIO, QGEN, IQV, IOVA, ABT, ARWR, DNLI, ARDX, COGT, HUM. UNH.
- Reduced shares in these 10 stocks: GILD (-$17M), TMO (-$13M), MRK (-$12M), BDX (-$7.8M), , , AMGN, CNC, CVS, EW.
- Sold out of its positions in CERT, CGON, HCA, REGN, TMO.
- Sector Gamma As was a net seller of stock by $-9.2M.
- Sector Gamma As has $424M in assets under management (AUM), dropping by -3.47%.
- Central Index Key (CIK): 0001475373
Tip: Access up to 7 years of quarterly data
Positions held by Sector Gamma ASA consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Portfolio Holdings for Sector Gamma As
Sector Gamma As holds 42 positions in its portfolio as reported in the March 2026 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price | |
|---|---|---|---|---|---|---|
| Bristol Myers Squibb (BMY) | 11.9 | $50M | +10% | 828k | 60.65 |
|
| Merck & Co (MRK) | 7.4 | $31M | -28% | 260k | 120.29 |
|
| Pfizer (PFE) | 7.2 | $31M | +26% | 1.1M | 28.08 |
|
| Medtronic SHS (MDT) | 5.7 | $24M | +4% | 281k | 86.65 |
|
| Incyte Corporation (INCY) | 4.5 | $19M | -8% | 201k | 94.12 |
|
| Amgen (AMGN) | 3.9 | $17M | -22% | 47k | 351.85 |
|
| Biogen Idec (BIIB) | 3.9 | $17M | +5% | 90k | 183.33 |
|
| Zimmer Holdings (ZBH) | 3.3 | $14M | +17% | 156k | 90.42 |
|
| BioMarin Pharmaceutical (BMRN) | 3.2 | $14M | +20% | 240k | 56.49 |
|
| Becton, Dickinson and (BDX) | 3.1 | $13M | -37% | 83k | 157.23 |
|
| Anthem (ELV) | 3.0 | $13M | +35% | 44k | 292.75 |
|
| Ionis Pharmaceuticals (IONS) | 3.0 | $13M | -8% | 170k | 75.09 |
|
| Cardinal Health (CAH) | 2.7 | $12M | -11% | 55k | 211.31 |
|
| UnitedHealth (UNH) | 2.3 | $9.9M | NEW | 36k | 270.59 |
|
| CVS Caremark Corporation (CVS) | 2.3 | $9.7M | -23% | 135k | 71.82 |
|
| Bruker Corporation (BRKR) | 2.2 | $9.2M | 254k | 36.12 |
|
|
| Ge Healthcare Technologies I Common Stock (GEHC) | 2.1 | $9.0M | +10% | 126k | 71.18 |
|
| Abbott Laboratories (ABT) | 2.1 | $9.0M | NEW | 88k | 102.67 |
|
| Gilead Sciences (GILD) | 1.8 | $7.4M | -69% | 53k | 139.37 |
|
| Lantheus Holdings Inc Common Stock Usd 0.01 (LNTH) | 1.7 | $7.1M | 93k | 75.85 |
|
|
| Iqvia Holdings (IQV) | 1.6 | $6.9M | NEW | 40k | 170.54 |
|
| Syndax Pharmaceuticals (SNDX) | 1.6 | $6.7M | +13% | 286k | 23.36 |
|
| Bio Rad Labs Cl A (BIO) | 1.6 | $6.6M | 24k | 278.75 |
|
|
| Qiagen Nv Ord Shares (QGEN) | 1.5 | $6.5M | NEW | 162k | 40.04 |
|
| Avantor (AVTR) | 1.3 | $5.5M | 695k | 7.84 |
|
|
| Centene Corporation (CNC) | 1.3 | $5.3M | -37% | 162k | 32.74 |
|
| Tandem Diabetes Care Com New (TNDM) | 1.2 | $5.1M | 267k | 19.17 |
|
|
| Ptc Therapeutics I (PTCT) | 1.2 | $5.1M | +21% | 75k | 68.13 |
|
| Labcorp Holdings Com Shs (LH) | 1.2 | $5.1M | -29% | 19k | 266.81 |
|
| Ascendis Pharma A/s Sponsored Adr (ASND) | 1.2 | $4.9M | +30% | 21k | 228.73 |
|
| Edwards Lifesciences (EW) | 1.1 | $4.8M | -37% | 60k | 80.08 |
|
| Dex (DXCM) | 0.8 | $3.5M | -26% | 56k | 62.80 |
|
| Crinetics Pharmaceuticals In (CRNX) | 0.8 | $3.4M | -18% | 94k | 36.32 |
|
| Kura Oncology (KURA) | 0.8 | $3.3M | -9% | 412k | 8.13 |
|
| Humana (HUM) | 0.8 | $3.3M | NEW | 19k | 173.39 |
|
| Bridgebio Pharma (BBIO) | 0.8 | $3.3M | NEW | 44k | 74.26 |
|
| Iovance Biotherapeutics (IOVA) | 0.7 | $3.2M | NEW | 900k | 3.51 |
|
| Denali Therapeutics (DNLI) | 0.7 | $3.1M | NEW | 163k | 19.20 |
|
| Ardelyx (ARDX) | 0.7 | $3.1M | NEW | 516k | 5.99 |
|
| Cogent Biosciences (COGT) | 0.7 | $3.1M | NEW | 80k | 38.49 |
|
| Organon & Co Common Stock (OGN) | 0.5 | $2.3M | +25% | 376k | 5.99 |
|
| Arrowhead Pharmaceuticals (ARWR) | 0.4 | $1.9M | NEW | 30k | 62.70 |
|
Past Filings by Sector Gamma As
SEC 13F filings are viewable for Sector Gamma As going back to 2010
- Sector Gamma As 2026 Q1 filed May 7, 2026
- Sector Gamma As 2025 Q4 filed Feb. 12, 2026
- Sector Gamma As 2025 Q3 filed Oct. 31, 2025
- Sector Gamma As 2025 Q2 filed July 31, 2025
- Sector Gamma As 2025 Q1 filed May 13, 2025
- Sector Gamma As 2024 Q4 filed Feb. 11, 2025
- Sector Gamma As 2024 Q3 filed Nov. 13, 2024
- Sector Gamma As 2024 Q2 filed Aug. 9, 2024
- Sector Gamma As 2024 Q1 filed May 8, 2024
- Sector Gamma As 2023 Q4 filed Feb. 5, 2024
- Sector Gamma As 2023 Q3 filed Nov. 6, 2023
- Sector Gamma As 2023 Q2 filed Aug. 9, 2023
- Sector Gamma As 2023 Q1 filed May 12, 2023
- Sector Gamma As 2022 Q4 restated filed Feb. 8, 2023
- Sector Gamma As 2022 Q4 filed Feb. 7, 2023
- Sector Gamma As 2022 Q3 filed Nov. 9, 2022